What is Diabetic Neuropathy and How Can It Affect You?
What is Diabetic Neuropathy and How Can It Affect You?
The Big Picture
Diabetic neuropathy is a nerve disorder caused by diabetes, leading to symptoms like pain and numbness in the feet. Understanding this condition is key to managing its effects and maintaining quality of life.
Contents
Understanding Diabetic Neuropathy
Diabetic neuropathy, specifically distal symmetric polyneuropathy (DSPN), is the most common nerve complication of diabetes. It often results in nerve damage starting in the toes and feet, causing symptoms such as pain and numbness. This condition not only affects sensory perception but also increases the risk of foot ulcers and amputations.
The Impact on Daily Life
Living with diabetic neuropathy can be challenging, as it often leads to pain and discomfort. Approximately 15 to 20 percent of those affected experience painful symptoms that can limit daily activities and reduce quality of life. Managing these symptoms is crucial to maintaining functionality and independence.
Why Prevention Matters
While established diabetic neuropathy is generally irreversible, preventing further progression is possible. Effective management focuses on controlling blood sugar levels and addressing risk factors like high blood pressure and cholesterol. These measures can help prevent complications such as ulcers and falls.
FAQs
What is diabetic neuropathy?
It's a nerve disorder caused by diabetes, affecting the feet and toes.
Who is most at risk?
People with diabetes, especially those with uncontrolled blood sugar levels.
Can diabetic neuropathy be reversed?
No, but its progression can be slowed with proper management.
What are common symptoms?
Symptoms include pain, numbness, and increased risk of foot ulcers.
Wrapping Up
Understanding diabetic neuropathy is crucial for managing its impacts and preventing complications.
Additional References
- Pop-Busui R, Boulton AJ, Feldman EL, et al. Diabetic Neuropathy: A Position Statement by the American Diabetes Association. Diabetes Care 2017; 40:136.
- Martin CL, Albers JW, Pop-Busui R, DCCT/EDIC Research Group. Neuropathy and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care 2014; 37:31.
- Callaghan BC, Little AA, Feldman EL, Hughes RA. Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane Database Syst Rev 2012; :CD007543.
This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic.